☆ 3.8 Article

The first experience of using prostate cancer organoids as a model for personalized selection of drugs

ONKOUROLOGIYA (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Establishment and characterization of prostate organoids from treatment-naive patients with prostate cancer

Katia Cheaito et al.

Summary: This study successfully generated and characterized patient-derived organoids from treatment-naive prostate cancer patients. These organoids mimicked the heterogeneity of tumor tissue and showed potential for predicting personalized treatment responses.

ONCOLOGY LETTERS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine

Sahithi Pamarthy et al.

Summary: Advancements in utilizing patient derived organoids (PDOs) for modeling prostate cancer have shown promise in predicting therapeutic responses and screening effective targeted therapies. Technological innovations in generating PDOs and incorporating various extracellular matrices have improved the accuracy and reliability of these models. PDOs, especially those derived from single cells, accurately represent the molecular features of the original tumor and serve as a reliable pre-clinical model for understanding individual tumors and designing tailored targeted therapies.

MOLECULAR CANCER (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells

Andrey Poloznikov et al.

Summary: Colorectal cancer is a common and lethal type of cancer, with limited chemotherapy options, highlighting the need for new targeted therapies. The GSK-3 beta inhibitor 9-ING-41 has shown to inhibit CRC cell growth through a mechanism distinct from chemotherapy. Further investigation of GSK-3 inhibitors in combination with standard-of-care treatment for CRC is warranted.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Oncology

Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens

Raphaelle Servant et al.

Summary: This study comprehensively analyzed 81 prostate cancer samples to identify factors influencing the generation of PDOs, revealing improved culture conditions but no specific intrinsic tumor feature associated with sustained organoid growth. Molecular and phenotypic characterization of tumor-organoid pairs provided fast identification of promising organoids, suggesting opportunities and challenges in establishing stable tumor organoid lines derived from PCa patients.

JOURNAL OF PATHOLOGY (2021)

添加到收藏夹

Review Oncology

Patient-Derived Cancer Organoids as Predictors of Treatment Response

Maikel Verduin et al.

Summary: Patient-derived cancer organoids are valuable tools in predicting individualized treatment responses, comparing treatment efficacies, and screening new anti-cancer drugs. However, further improvements are needed to fully utilize the potential of cancer organoids in clinical cancer therapy management.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Breast cancer organoid model allowed to reveal potentially beneficial combinations of 3,3′-diindolylmethane and chemotherapy drugs

Sergey V. Nikulin et al.

BIOCHIMIE (2020)

添加到收藏夹

Review Urology & Nephrology

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

Philipp Nuhn et al.

EUROPEAN UROLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

Norman Sachs et al.

CELL (2018)

添加到收藏夹

Review Medicine, General & Internal

Metastatic Prostate Cancer

Oliver Sartor et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

添加到收藏夹

Review Oncology

Organoids in cancer research

Jarno Drost et al.

NATURE REVIEWS CANCER (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery

Fleur Weeber et al.

CELL CHEMICAL BIOLOGY (2017)

添加到收藏夹

Review Oncology

Clinically Relevant Concentrations of Anticancer Drugs: A Guide for Nonclinical Studies

Dane R. Liston et al.

CLINICAL CANCER RESEARCH (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

Marc van de Wetering et al.

CELL (2015)

添加到收藏夹

Review Oncology

Personalised cancer medicine

Sarah E. Jackson et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Dong Gao et al.

CELL (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.